Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed supply chain issues for delaying its regulatory timeline.
Monogram Technologies (Nasdaq:MGRM) announced today that it received FDA 510(k) clearance for its mBôs total knee ...
Monogram Technologies earned FDA 510(k) clearance for its Monogram mBôs robot, according to a March 17 news release. The ...
Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).
On Monday, the U.S. Food and Drug Administration (FDA) granted 510(k) clearance for Monogram Technologies Inc.’s (NASDAQ:MGRM ...
TipRanks on MSN2d
Monogram Orthopaedics Gains FDA Clearance for TKA SystemMonogram Orthopaedics Inc ( ($MGRM) ) has issued an update. On March 17, 2025, Monogram Technologies Inc. announced that it received FDA 510(k) ...
Management to Host Business Update Conference Call on Wednesday, March 12, 2025, at 4:30 p.m. Eastern Time AUSTIN, TX / ACCESS Newswire / March 12, 2025 / Monogram Technologies Inc. (NASDAQ ...
Hosted on MSN20d
MGRM: Monogram’s Potential for 2025 Commercialization of its mBôs Total Knee Arthroplasty Robotic System Supports Price Target of $6.00.On February 26, 2025, Monogram (NASDAQ:MGRM) announced an update regarding its 510(k) premarket filing submission ... remarkable for a completely hands-free, unconstrained autonomous system.
Monogram received FDA 510(k) clearance for its robotic-assisted total knee arthroplasty system, Monogram mBôs TKA. The company plans initial placements with key surgeons and aims to expand its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback